What’s the current market cap for Demant A/S stock?

Demant A/S (DEMANT) has a market cap of €6.9bn as of June 19, 2026.

What is the P/E ratio for Demant A/S stock?

The price to earnings (P/E) ratio for Demant A/S (DEMANT) stock is 33.3 as of June 19, 2026.

Does Demant A/S stock pay dividends?

No, Demant A/S (DEMANT) stock does not pay dividends to its shareholders as of June 19, 2026.

When is the next Demant A/S dividend payment date?

Demant A/S (DEMANT) stock does not pay dividends to its shareholders.

What is the beta indicator for Demant A/S?

Demant A/S (DEMANT) has a beta rating of 0.71. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Demant A/S stock | €DEMANT Share Price

05:30

09:10

12:45

16:25

20:00

About Demant A/S

Demant A/S is a company specializing in hearing healthcare solutions. It operates in the medical technology industry, providing hearing aids, audiometric equipment, and hearing implants. The company also offers personal communication solutions and hearing care services through its retail network. Founded in 1904 and headquartered in Smørum, Denmark, Demant has a significant presence in Europe, North America, and other regions, serving users worldwide. The company's strategic positioning is strengthened by its focus on R&D and innovation, which supports its diverse product portfolio and ability to meet various customer needs in the hearing health market.

Ticker

€DEMANT

Sector

Health

Primary listing

XGAT

Employees

25,077

Headquarters

Smørum, Denmark

Website

www.demant.com

Demant A/S Metrics

BasicAdvanced

€6.9bn

33.30

€0.98

0.71

Bulls say / Bears say

Demant’s Q1 2026 net sales rose 11.1% to DKK 6,246 m, exceeding the consensus estimate of DKK 6,081 m by 2.7%.

Organic external revenue in the Hearing Aids segment grew 9% in Q1 2026, driven by the successful launch of Oticon Zeal and resulting market share gains.

Jefferies upgraded Demant to ‘buy’ with a DKK 245 price target, suggesting 32% upside, noting the stock trades at about 19x CY26 P/E, roughly 10% below its 10-year average.

Amplifon’s acquisition of GN Store Nord’s hearing-aid business for DKK 17 bn is expected to intensify competition, potentially eroding Demant’s market share given the slow demand in the industry.

Bank of America has cut its price target for Demant to the lowest among analysts tracked by Bloomberg, citing the need for clearer signs of growth acceleration before turning more positive.

Demant anticipates the global hearing-aid market will grow just 2–4% in 2026, below its mid-to-long-term expectations, pointing to the risk of muted demand and pricing pressure.

Data summarised monthly by Lightyear AI. Last updated on 31 May 2026.

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Market data provided by CBOE Europe and Deutsche Börse.

Bulls say / Bears say

Demant’s Q1 2026 net sales rose 11.1% to DKK 6,246 m, exceeding the consensus estimate of DKK 6,081 m by 2.7%.

Organic external revenue in the Hearing Aids segment grew 9% in Q1 2026, driven by the successful launch of Oticon Zeal and resulting market share gains.

Jefferies upgraded Demant to ‘buy’ with a DKK 245 price target, suggesting 32% upside, noting the stock trades at about 19x CY26 P/E, roughly 10% below its 10-year average.

Bank of America has cut its price target for Demant to the lowest among analysts tracked by Bloomberg, citing the need for clearer signs of growth acceleration before turning more positive.

Demant anticipates the global hearing-aid market will grow just 2–4% in 2026, below its mid-to-long-term expectations, pointing to the risk of muted demand and pricing pressure.

Data summarised monthly by Lightyear AI. Last updated on 31 May 2026.

About Demant A/S

Ticker

Primary listing

Employees

Headquarters

Demant A/S Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

Bulls say / Bears say

Buy €DEMANT

Lightyear

Legal

Work with us

Bulls say / Bears say

Demant A/S/€DEMANT

About Demant A/S

Ticker

Primary listing

Employees

Headquarters

Demant A/S Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

Bulls say / Bears say

What’s the current market cap for Demant A/S stock?

What is the P/E ratio for Demant A/S stock?

Does Demant A/S stock pay dividends?

When is the next Demant A/S dividend payment date?

What is the beta indicator for Demant A/S?

Bulls say / Bears say